Clinical Trials Logo

Clinical Trial Summary

The purpose of this pilot study is to determine if the use of Purell hand sanitizer alters the duration, level of pain and discomfort during treatment, and the size of the HSV-1 lesion. The duration of an HSV-1 (herpes) lesion is the primary endpoint for this study. Size, pain, and discomfort are the secondary endpoints.


Clinical Trial Description

The participants will be divided into a control group (10 participants) and treatment group (10 participants) and will be given either the Purell hand sanitizer (treatment group) or medical grade mineral oil (control group) to treat the lesion. Participants will apply a large drop of the product (purell hand sanitizer or mineral oil) on a q-tip and will hold the q-tip on the lesion for 10 seconds. Participants will be instructed to apply a solution to lesion every waking hour for the next 14 days or until lesion has healed. Each day the participant will fill out the daily journal. The journal includes a measurement in millimeters of the lesion with graph paper, recorded number of applications for that day, and two visual analog scales- one measuring any discomfort from the lesion and the other recording the pain during the application process. Documentation of changes to the lesion will be recorded in a daily journal until the lesion is healed. There are two days that the participants are expected to return to the clinic for re-examination at day three and the last day when the lesion has healed, or the crust has fallen off. Pictures of the lesion will taken at these two points in time. The duration the HSV-1 lesion, level of pain and discomfort during treatment, and the size of the HSV-1 lesion will be statistically measured between the control group (mineral oil) and the treatment group (purell hand sanitizer) to determine if there is any statistical difference between the two groups. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06135844
Study type Interventional
Source Idaho State University
Contact Leciel Bono, MS
Phone 2082823076
Email bonoleci@isu.edu
Status Recruiting
Phase Early Phase 1
Start date April 8, 2022
Completion date November 30, 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03911388 - HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors Phase 1
Recruiting NCT06059027 - Microbes and Respiratory Illnesses
Completed NCT03463694 - Edinburgh and Lothian Virus Intervention Study in Kids N/A
Recruiting NCT04393415 - Using PRP and Cord Blood in Treatment of Covid -19 N/A
Not yet recruiting NCT05387226 - Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma Phase 1
Active, not recruiting NCT05064462 - TTV Viral Load in Heart Transplant Recipients
Recruiting NCT04336020 - The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study
Recruiting NCT05727709 - Dynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients
Recruiting NCT04382131 - Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19) N/A
Completed NCT02743663 - The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children
Not yet recruiting NCT06396624 - Effects of Photobiomodulation on the Innate Immune System of Neonates and Infants With Bronchiolitis N/A
Not yet recruiting NCT06432855 - Genetic Determinants of the Antiviral Immune Response in Oceanian Populations N/A
Not yet recruiting NCT05868551 - Onchocerciasis-Associated Epilepsy, an Explorative Case-control Study
Completed NCT01136395 - Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation Phase 2
Completed NCT01159561 - Western Equine Encephalitis Vaccine, Inactivated Phase 1
Completed NCT04636294 - Borderline COVID-19 PCR Test Result
Recruiting NCT04449978 - TARGet Kids! COVID-19 Study of Children and Families
Recruiting NCT04348864 - COVID-19 Diagnostic Self-testing Using Virtual Point-of-care N/A